nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.072	0.15	CrCrCtD
Doxepin—Doxylamine—Tamoxifen—pancreatic cancer	0.0662	0.138	CrCrCtD
Doxepin—Tripelennamine—Tamoxifen—pancreatic cancer	0.0599	0.125	CrCrCtD
Doxepin—Dimetacrine—Tamoxifen—pancreatic cancer	0.056	0.116	CrCrCtD
Doxepin—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.056	0.116	CrCrCtD
Doxepin—Clofedanol—Tamoxifen—pancreatic cancer	0.0455	0.0946	CrCrCtD
Doxepin—Orphenadrine—Tamoxifen—pancreatic cancer	0.044	0.0915	CrCrCtD
Doxepin—ORM1—Erlotinib—pancreatic cancer	0.0428	0.167	CbGbCtD
Doxepin—Promazine—Tamoxifen—pancreatic cancer	0.042	0.0873	CrCrCtD
Doxepin—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0391	0.0813	CrCrCtD
Doxepin—KCNH2—Sunitinib—pancreatic cancer	0.0249	0.0968	CbGbCtD
Doxepin—CYP1A2—Dacarbazine—pancreatic cancer	0.0159	0.062	CbGbCtD
Doxepin—CYP2C19—Tamoxifen—pancreatic cancer	0.0137	0.0535	CbGbCtD
Doxepin—CYP1A2—Tamoxifen—pancreatic cancer	0.0127	0.0493	CbGbCtD
Doxepin—CYP2C9—Tamoxifen—pancreatic cancer	0.0114	0.0444	CbGbCtD
Doxepin—ABCB1—Tamoxifen—pancreatic cancer	0.0111	0.0431	CbGbCtD
Doxepin—CYP1A2—Erlotinib—pancreatic cancer	0.0108	0.0419	CbGbCtD
Doxepin—CYP2D6—Tamoxifen—pancreatic cancer	0.0104	0.0406	CbGbCtD
Doxepin—HRH2—gastric juice—pancreatic cancer	0.0102	0.424	CbGeAlD
Doxepin—ABCB1—Gemcitabine—pancreatic cancer	0.00955	0.0372	CbGbCtD
Doxepin—ABCB1—Erlotinib—pancreatic cancer	0.00942	0.0367	CbGbCtD
Doxepin—CYP1A2—Fluorouracil—pancreatic cancer	0.00934	0.0363	CbGbCtD
Doxepin—CYP2D6—Erlotinib—pancreatic cancer	0.00888	0.0346	CbGbCtD
Doxepin—ABCB1—Irinotecan—pancreatic cancer	0.00851	0.0331	CbGbCtD
Doxepin—CYP2C9—Fluorouracil—pancreatic cancer	0.00841	0.0327	CbGbCtD
Doxepin—CYP3A4—Tamoxifen—pancreatic cancer	0.00664	0.0258	CbGbCtD
Doxepin—ABCB1—Docetaxel—pancreatic cancer	0.00624	0.0243	CbGbCtD
Doxepin—ABCB1—Sunitinib—pancreatic cancer	0.00621	0.0242	CbGbCtD
Doxepin—CYP3A4—Erlotinib—pancreatic cancer	0.00565	0.022	CbGbCtD
Doxepin—CYP3A4—Irinotecan—pancreatic cancer	0.0051	0.0198	CbGbCtD
Doxepin—ABCB1—Doxorubicin—pancreatic cancer	0.00465	0.0181	CbGbCtD
Doxepin—CYP2D6—Doxorubicin—pancreatic cancer	0.00438	0.017	CbGbCtD
Doxepin—ORM1—bile—pancreatic cancer	0.00399	0.167	CbGeAlD
Doxepin—CYP3A4—Docetaxel—pancreatic cancer	0.00374	0.0145	CbGbCtD
Doxepin—CYP3A4—Sunitinib—pancreatic cancer	0.00372	0.0145	CbGbCtD
Doxepin—HTR2A—enteric nervous system—pancreatic cancer	0.00343	0.143	CbGeAlD
Doxepin—CYP3A4—Doxorubicin—pancreatic cancer	0.00279	0.0108	CbGbCtD
Doxepin—ORM1—gall bladder—pancreatic cancer	0.00111	0.0463	CbGeAlD
Doxepin—HRH2—digestive system—pancreatic cancer	0.00062	0.0259	CbGeAlD
Doxepin—KCNH2—islet of Langerhans—pancreatic cancer	0.000489	0.0204	CbGeAlD
Doxepin—ADRA2A—islet of Langerhans—pancreatic cancer	0.000385	0.0161	CbGeAlD
Doxepin—SLC6A4—digestive system—pancreatic cancer	0.000372	0.0155	CbGeAlD
Doxepin—HTR2B—digestive system—pancreatic cancer	0.000368	0.0154	CbGeAlD
Doxepin—ADRA2C—pancreas—pancreatic cancer	0.000339	0.0142	CbGeAlD
Doxepin—CHRM3—digestive system—pancreatic cancer	0.000331	0.0138	CbGeAlD
Doxepin—CYP2C19—digestive system—pancreatic cancer	0.000308	0.0129	CbGeAlD
Doxepin—ADRA2A—pancreas—pancreatic cancer	0.000271	0.0113	CbGeAlD
Doxepin—CYP1A2—digestive system—pancreatic cancer	0.000252	0.0105	CbGeAlD
Doxepin—CYP2C9—digestive system—pancreatic cancer	0.000239	0.00996	CbGeAlD
Doxepin—HRH1—digestive system—pancreatic cancer	0.000236	0.00983	CbGeAlD
Doxepin—ABCB1—islet of Langerhans—pancreatic cancer	0.000215	0.00896	CbGeAlD
Doxepin—HTR2A—digestive system—pancreatic cancer	0.000197	0.00821	CbGeAlD
Doxepin—CYP3A4—digestive system—pancreatic cancer	0.000182	0.0076	CbGeAlD
Doxepin—CYP2D6—digestive system—pancreatic cancer	0.000179	0.00748	CbGeAlD
Doxepin—ABCB1—pancreas—pancreatic cancer	0.000151	0.0063	CbGeAlD
Doxepin—ABCB1—digestive system—pancreatic cancer	0.000129	0.00538	CbGeAlD
Doxepin—Jaundice—Epirubicin—pancreatic cancer	8.13e-05	0.000608	CcSEcCtD
Doxepin—Urinary tract infection—Epirubicin—pancreatic cancer	8.11e-05	0.000606	CcSEcCtD
Doxepin—Dysuria—Doxorubicin—pancreatic cancer	8.09e-05	0.000605	CcSEcCtD
Doxepin—Hypersensitivity—Fluorouracil—pancreatic cancer	8.05e-05	0.000602	CcSEcCtD
Doxepin—Dry mouth—Docetaxel—pancreatic cancer	8.04e-05	0.000601	CcSEcCtD
Doxepin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	8.04e-05	0.000601	CcSEcCtD
Doxepin—Sweating—Epirubicin—pancreatic cancer	7.99e-05	0.000598	CcSEcCtD
Doxepin—Pollakiuria—Doxorubicin—pancreatic cancer	7.99e-05	0.000598	CcSEcCtD
Doxepin—Asthenia—Gemcitabine—pancreatic cancer	7.97e-05	0.000596	CcSEcCtD
Doxepin—Confusional state—Docetaxel—pancreatic cancer	7.95e-05	0.000594	CcSEcCtD
Doxepin—Hepatobiliary disease—Epirubicin—pancreatic cancer	7.89e-05	0.00059	CcSEcCtD
Doxepin—Oedema—Docetaxel—pancreatic cancer	7.89e-05	0.000589	CcSEcCtD
Doxepin—Weight increased—Doxorubicin—pancreatic cancer	7.88e-05	0.000589	CcSEcCtD
Doxepin—Pruritus—Gemcitabine—pancreatic cancer	7.86e-05	0.000588	CcSEcCtD
Doxepin—Infection—Docetaxel—pancreatic cancer	7.83e-05	0.000586	CcSEcCtD
Doxepin—Sinusitis—Epirubicin—pancreatic cancer	7.82e-05	0.000585	CcSEcCtD
Doxepin—Diarrhoea—Irinotecan—pancreatic cancer	7.8e-05	0.000583	CcSEcCtD
Doxepin—Agranulocytosis—Epirubicin—pancreatic cancer	7.78e-05	0.000582	CcSEcCtD
Doxepin—Pneumonia—Doxorubicin—pancreatic cancer	7.76e-05	0.00058	CcSEcCtD
Doxepin—Shock—Docetaxel—pancreatic cancer	7.76e-05	0.00058	CcSEcCtD
Doxepin—Nervous system disorder—Docetaxel—pancreatic cancer	7.73e-05	0.000578	CcSEcCtD
Doxepin—Pruritus—Fluorouracil—pancreatic cancer	7.73e-05	0.000578	CcSEcCtD
Doxepin—Thrombocytopenia—Docetaxel—pancreatic cancer	7.72e-05	0.000577	CcSEcCtD
Doxepin—Drowsiness—Doxorubicin—pancreatic cancer	7.72e-05	0.000577	CcSEcCtD
Doxepin—Infestation NOS—Doxorubicin—pancreatic cancer	7.72e-05	0.000577	CcSEcCtD
Doxepin—Infestation—Doxorubicin—pancreatic cancer	7.72e-05	0.000577	CcSEcCtD
Doxepin—Tachycardia—Docetaxel—pancreatic cancer	7.7e-05	0.000575	CcSEcCtD
Doxepin—Skin disorder—Docetaxel—pancreatic cancer	7.66e-05	0.000573	CcSEcCtD
Doxepin—Bradycardia—Epirubicin—pancreatic cancer	7.62e-05	0.00057	CcSEcCtD
Doxepin—Diarrhoea—Gemcitabine—pancreatic cancer	7.6e-05	0.000568	CcSEcCtD
Doxepin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	7.56e-05	0.000565	CcSEcCtD
Doxepin—Dizziness—Irinotecan—pancreatic cancer	7.54e-05	0.000564	CcSEcCtD
Doxepin—Stomatitis—Doxorubicin—pancreatic cancer	7.52e-05	0.000562	CcSEcCtD
Doxepin—Jaundice—Doxorubicin—pancreatic cancer	7.52e-05	0.000562	CcSEcCtD
Doxepin—Anorexia—Docetaxel—pancreatic cancer	7.52e-05	0.000562	CcSEcCtD
Doxepin—Urinary tract infection—Doxorubicin—pancreatic cancer	7.5e-05	0.000561	CcSEcCtD
Doxepin—Hepatitis—Epirubicin—pancreatic cancer	7.49e-05	0.00056	CcSEcCtD
Doxepin—Diarrhoea—Fluorouracil—pancreatic cancer	7.48e-05	0.000559	CcSEcCtD
Doxepin—Hypoaesthesia—Epirubicin—pancreatic cancer	7.45e-05	0.000557	CcSEcCtD
Doxepin—Pharyngitis—Epirubicin—pancreatic cancer	7.43e-05	0.000555	CcSEcCtD
Doxepin—Sweating—Doxorubicin—pancreatic cancer	7.4e-05	0.000553	CcSEcCtD
Doxepin—Urinary tract disorder—Epirubicin—pancreatic cancer	7.39e-05	0.000553	CcSEcCtD
Doxepin—Oedema peripheral—Epirubicin—pancreatic cancer	7.37e-05	0.000551	CcSEcCtD
Doxepin—Hypotension—Docetaxel—pancreatic cancer	7.37e-05	0.000551	CcSEcCtD
Doxepin—Connective tissue disorder—Epirubicin—pancreatic cancer	7.36e-05	0.00055	CcSEcCtD
Doxepin—Urethral disorder—Epirubicin—pancreatic cancer	7.34e-05	0.000549	CcSEcCtD
Doxepin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	7.3e-05	0.000546	CcSEcCtD
Doxepin—Vomiting—Irinotecan—pancreatic cancer	7.25e-05	0.000542	CcSEcCtD
Doxepin—Sinusitis—Doxorubicin—pancreatic cancer	7.24e-05	0.000541	CcSEcCtD
Doxepin—Dizziness—Fluorouracil—pancreatic cancer	7.22e-05	0.00054	CcSEcCtD
Doxepin—Agranulocytosis—Doxorubicin—pancreatic cancer	7.2e-05	0.000538	CcSEcCtD
Doxepin—Rash—Irinotecan—pancreatic cancer	7.19e-05	0.000538	CcSEcCtD
Doxepin—Dermatitis—Irinotecan—pancreatic cancer	7.19e-05	0.000537	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.18e-05	0.000537	CcSEcCtD
Doxepin—Headache—Irinotecan—pancreatic cancer	7.15e-05	0.000534	CcSEcCtD
Doxepin—Insomnia—Docetaxel—pancreatic cancer	7.13e-05	0.000533	CcSEcCtD
Doxepin—Paraesthesia—Docetaxel—pancreatic cancer	7.08e-05	0.000529	CcSEcCtD
Doxepin—Vomiting—Gemcitabine—pancreatic cancer	7.06e-05	0.000528	CcSEcCtD
Doxepin—Bradycardia—Doxorubicin—pancreatic cancer	7.05e-05	0.000527	CcSEcCtD
Doxepin—Dyspnoea—Docetaxel—pancreatic cancer	7.03e-05	0.000526	CcSEcCtD
Doxepin—Somnolence—Docetaxel—pancreatic cancer	7.01e-05	0.000524	CcSEcCtD
Doxepin—Rash—Gemcitabine—pancreatic cancer	7.01e-05	0.000524	CcSEcCtD
Doxepin—Dermatitis—Gemcitabine—pancreatic cancer	7e-05	0.000523	CcSEcCtD
Doxepin—Eye disorder—Epirubicin—pancreatic cancer	7e-05	0.000523	CcSEcCtD
Doxepin—Tinnitus—Epirubicin—pancreatic cancer	6.98e-05	0.000522	CcSEcCtD
Doxepin—Headache—Gemcitabine—pancreatic cancer	6.96e-05	0.00052	CcSEcCtD
Doxepin—Flushing—Epirubicin—pancreatic cancer	6.95e-05	0.000519	CcSEcCtD
Doxepin—Cardiac disorder—Epirubicin—pancreatic cancer	6.95e-05	0.000519	CcSEcCtD
Doxepin—Vomiting—Fluorouracil—pancreatic cancer	6.95e-05	0.000519	CcSEcCtD
Doxepin—Dyspepsia—Docetaxel—pancreatic cancer	6.94e-05	0.000519	CcSEcCtD
Doxepin—Hepatitis—Doxorubicin—pancreatic cancer	6.93e-05	0.000518	CcSEcCtD
Doxepin—Hypoaesthesia—Doxorubicin—pancreatic cancer	6.89e-05	0.000515	CcSEcCtD
Doxepin—Rash—Fluorouracil—pancreatic cancer	6.89e-05	0.000515	CcSEcCtD
Doxepin—Dermatitis—Fluorouracil—pancreatic cancer	6.88e-05	0.000514	CcSEcCtD
Doxepin—Pharyngitis—Doxorubicin—pancreatic cancer	6.87e-05	0.000514	CcSEcCtD
Doxepin—Decreased appetite—Docetaxel—pancreatic cancer	6.85e-05	0.000512	CcSEcCtD
Doxepin—Headache—Fluorouracil—pancreatic cancer	6.84e-05	0.000512	CcSEcCtD
Doxepin—Urinary tract disorder—Doxorubicin—pancreatic cancer	6.84e-05	0.000511	CcSEcCtD
Doxepin—Oedema peripheral—Doxorubicin—pancreatic cancer	6.82e-05	0.00051	CcSEcCtD
Doxepin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	6.81e-05	0.000509	CcSEcCtD
Doxepin—Connective tissue disorder—Doxorubicin—pancreatic cancer	6.81e-05	0.000509	CcSEcCtD
Doxepin—Fatigue—Docetaxel—pancreatic cancer	6.8e-05	0.000508	CcSEcCtD
Doxepin—Angiopathy—Epirubicin—pancreatic cancer	6.79e-05	0.000508	CcSEcCtD
Doxepin—Urethral disorder—Doxorubicin—pancreatic cancer	6.79e-05	0.000508	CcSEcCtD
Doxepin—Nausea—Irinotecan—pancreatic cancer	6.78e-05	0.000506	CcSEcCtD
Doxepin—Immune system disorder—Epirubicin—pancreatic cancer	6.76e-05	0.000505	CcSEcCtD
Doxepin—Mediastinal disorder—Epirubicin—pancreatic cancer	6.75e-05	0.000504	CcSEcCtD
Doxepin—Constipation—Docetaxel—pancreatic cancer	6.74e-05	0.000504	CcSEcCtD
Doxepin—Pain—Docetaxel—pancreatic cancer	6.74e-05	0.000504	CcSEcCtD
Doxepin—Chills—Epirubicin—pancreatic cancer	6.72e-05	0.000502	CcSEcCtD
Doxepin—Arrhythmia—Epirubicin—pancreatic cancer	6.69e-05	0.0005	CcSEcCtD
Doxepin—Alopecia—Epirubicin—pancreatic cancer	6.62e-05	0.000495	CcSEcCtD
Doxepin—Nausea—Gemcitabine—pancreatic cancer	6.6e-05	0.000493	CcSEcCtD
Doxepin—Mental disorder—Epirubicin—pancreatic cancer	6.56e-05	0.00049	CcSEcCtD
Doxepin—Erythema—Epirubicin—pancreatic cancer	6.52e-05	0.000487	CcSEcCtD
Doxepin—Malnutrition—Epirubicin—pancreatic cancer	6.52e-05	0.000487	CcSEcCtD
Doxepin—Feeling abnormal—Docetaxel—pancreatic cancer	6.5e-05	0.000486	CcSEcCtD
Doxepin—Nausea—Fluorouracil—pancreatic cancer	6.49e-05	0.000485	CcSEcCtD
Doxepin—Eye disorder—Doxorubicin—pancreatic cancer	6.47e-05	0.000484	CcSEcCtD
Doxepin—Tinnitus—Doxorubicin—pancreatic cancer	6.46e-05	0.000483	CcSEcCtD
Doxepin—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.45e-05	0.000482	CcSEcCtD
Doxepin—Flushing—Doxorubicin—pancreatic cancer	6.43e-05	0.000481	CcSEcCtD
Doxepin—Cardiac disorder—Doxorubicin—pancreatic cancer	6.43e-05	0.000481	CcSEcCtD
Doxepin—Flatulence—Epirubicin—pancreatic cancer	6.42e-05	0.00048	CcSEcCtD
Doxepin—Tension—Epirubicin—pancreatic cancer	6.4e-05	0.000478	CcSEcCtD
Doxepin—Dysgeusia—Epirubicin—pancreatic cancer	6.38e-05	0.000477	CcSEcCtD
Doxepin—Nervousness—Epirubicin—pancreatic cancer	6.33e-05	0.000473	CcSEcCtD
Doxepin—Back pain—Epirubicin—pancreatic cancer	6.3e-05	0.000471	CcSEcCtD
Doxepin—Angiopathy—Doxorubicin—pancreatic cancer	6.28e-05	0.00047	CcSEcCtD
Doxepin—Muscle spasms—Epirubicin—pancreatic cancer	6.27e-05	0.000468	CcSEcCtD
Doxepin—Immune system disorder—Doxorubicin—pancreatic cancer	6.26e-05	0.000468	CcSEcCtD
Doxepin—Mediastinal disorder—Doxorubicin—pancreatic cancer	6.24e-05	0.000467	CcSEcCtD
Doxepin—Abdominal pain—Docetaxel—pancreatic cancer	6.23e-05	0.000466	CcSEcCtD
Doxepin—Body temperature increased—Docetaxel—pancreatic cancer	6.23e-05	0.000466	CcSEcCtD
Doxepin—Chills—Doxorubicin—pancreatic cancer	6.22e-05	0.000465	CcSEcCtD
Doxepin—Arrhythmia—Doxorubicin—pancreatic cancer	6.19e-05	0.000463	CcSEcCtD
Doxepin—Vision blurred—Epirubicin—pancreatic cancer	6.14e-05	0.000459	CcSEcCtD
Doxepin—Alopecia—Doxorubicin—pancreatic cancer	6.12e-05	0.000458	CcSEcCtD
Doxepin—Mental disorder—Doxorubicin—pancreatic cancer	6.07e-05	0.000454	CcSEcCtD
Doxepin—Ill-defined disorder—Epirubicin—pancreatic cancer	6.05e-05	0.000452	CcSEcCtD
Doxepin—Erythema—Doxorubicin—pancreatic cancer	6.03e-05	0.000451	CcSEcCtD
Doxepin—Malnutrition—Doxorubicin—pancreatic cancer	6.03e-05	0.000451	CcSEcCtD
Doxepin—Anaemia—Epirubicin—pancreatic cancer	6.02e-05	0.00045	CcSEcCtD
Doxepin—Agitation—Epirubicin—pancreatic cancer	5.99e-05	0.000448	CcSEcCtD
Doxepin—Flatulence—Doxorubicin—pancreatic cancer	5.94e-05	0.000444	CcSEcCtD
Doxepin—Tension—Doxorubicin—pancreatic cancer	5.92e-05	0.000442	CcSEcCtD
Doxepin—Dysgeusia—Doxorubicin—pancreatic cancer	5.9e-05	0.000441	CcSEcCtD
Doxepin—Malaise—Epirubicin—pancreatic cancer	5.88e-05	0.000439	CcSEcCtD
Doxepin—Nervousness—Doxorubicin—pancreatic cancer	5.86e-05	0.000438	CcSEcCtD
Doxepin—Vertigo—Epirubicin—pancreatic cancer	5.86e-05	0.000438	CcSEcCtD
Doxepin—Syncope—Epirubicin—pancreatic cancer	5.84e-05	0.000437	CcSEcCtD
Doxepin—Leukopenia—Epirubicin—pancreatic cancer	5.83e-05	0.000436	CcSEcCtD
Doxepin—Back pain—Doxorubicin—pancreatic cancer	5.83e-05	0.000436	CcSEcCtD
Doxepin—Hypersensitivity—Docetaxel—pancreatic cancer	5.81e-05	0.000434	CcSEcCtD
Doxepin—Muscle spasms—Doxorubicin—pancreatic cancer	5.8e-05	0.000433	CcSEcCtD
Doxepin—Palpitations—Epirubicin—pancreatic cancer	5.76e-05	0.00043	CcSEcCtD
Doxepin—Loss of consciousness—Epirubicin—pancreatic cancer	5.73e-05	0.000428	CcSEcCtD
Doxepin—Cough—Epirubicin—pancreatic cancer	5.69e-05	0.000425	CcSEcCtD
Doxepin—Vision blurred—Doxorubicin—pancreatic cancer	5.68e-05	0.000425	CcSEcCtD
Doxepin—Asthenia—Docetaxel—pancreatic cancer	5.66e-05	0.000423	CcSEcCtD
Doxepin—Convulsion—Epirubicin—pancreatic cancer	5.65e-05	0.000422	CcSEcCtD
Doxepin—Hypertension—Epirubicin—pancreatic cancer	5.63e-05	0.000421	CcSEcCtD
Doxepin—Ill-defined disorder—Doxorubicin—pancreatic cancer	5.59e-05	0.000418	CcSEcCtD
Doxepin—Pruritus—Docetaxel—pancreatic cancer	5.58e-05	0.000417	CcSEcCtD
Doxepin—Anaemia—Doxorubicin—pancreatic cancer	5.57e-05	0.000417	CcSEcCtD
Doxepin—Arthralgia—Epirubicin—pancreatic cancer	5.55e-05	0.000415	CcSEcCtD
Doxepin—Myalgia—Epirubicin—pancreatic cancer	5.55e-05	0.000415	CcSEcCtD
Doxepin—Chest pain—Epirubicin—pancreatic cancer	5.55e-05	0.000415	CcSEcCtD
Doxepin—Agitation—Doxorubicin—pancreatic cancer	5.54e-05	0.000414	CcSEcCtD
Doxepin—Anxiety—Epirubicin—pancreatic cancer	5.53e-05	0.000413	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	5.51e-05	0.000412	CcSEcCtD
Doxepin—Discomfort—Epirubicin—pancreatic cancer	5.48e-05	0.00041	CcSEcCtD
Doxepin—Malaise—Doxorubicin—pancreatic cancer	5.44e-05	0.000406	CcSEcCtD
Doxepin—Dry mouth—Epirubicin—pancreatic cancer	5.43e-05	0.000406	CcSEcCtD
Doxepin—Vertigo—Doxorubicin—pancreatic cancer	5.42e-05	0.000405	CcSEcCtD
Doxepin—Syncope—Doxorubicin—pancreatic cancer	5.41e-05	0.000404	CcSEcCtD
Doxepin—Leukopenia—Doxorubicin—pancreatic cancer	5.4e-05	0.000403	CcSEcCtD
Doxepin—Diarrhoea—Docetaxel—pancreatic cancer	5.4e-05	0.000403	CcSEcCtD
Doxepin—Confusional state—Epirubicin—pancreatic cancer	5.36e-05	0.000401	CcSEcCtD
Doxepin—Palpitations—Doxorubicin—pancreatic cancer	5.33e-05	0.000398	CcSEcCtD
Doxepin—Oedema—Epirubicin—pancreatic cancer	5.32e-05	0.000398	CcSEcCtD
Doxepin—Loss of consciousness—Doxorubicin—pancreatic cancer	5.3e-05	0.000396	CcSEcCtD
Doxepin—Infection—Epirubicin—pancreatic cancer	5.28e-05	0.000395	CcSEcCtD
Doxepin—Cough—Doxorubicin—pancreatic cancer	5.26e-05	0.000393	CcSEcCtD
Doxepin—Shock—Epirubicin—pancreatic cancer	5.23e-05	0.000391	CcSEcCtD
Doxepin—Convulsion—Doxorubicin—pancreatic cancer	5.22e-05	0.000391	CcSEcCtD
Doxepin—Nervous system disorder—Epirubicin—pancreatic cancer	5.22e-05	0.00039	CcSEcCtD
Doxepin—Dizziness—Docetaxel—pancreatic cancer	5.21e-05	0.00039	CcSEcCtD
Doxepin—Thrombocytopenia—Epirubicin—pancreatic cancer	5.21e-05	0.000389	CcSEcCtD
Doxepin—Hypertension—Doxorubicin—pancreatic cancer	5.21e-05	0.000389	CcSEcCtD
Doxepin—Tachycardia—Epirubicin—pancreatic cancer	5.19e-05	0.000388	CcSEcCtD
Doxepin—Skin disorder—Epirubicin—pancreatic cancer	5.17e-05	0.000386	CcSEcCtD
Doxepin—Hyperhidrosis—Epirubicin—pancreatic cancer	5.14e-05	0.000384	CcSEcCtD
Doxepin—Chest pain—Doxorubicin—pancreatic cancer	5.13e-05	0.000384	CcSEcCtD
Doxepin—Arthralgia—Doxorubicin—pancreatic cancer	5.13e-05	0.000384	CcSEcCtD
Doxepin—Myalgia—Doxorubicin—pancreatic cancer	5.13e-05	0.000384	CcSEcCtD
Doxepin—Anxiety—Doxorubicin—pancreatic cancer	5.12e-05	0.000382	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.1e-05	0.000381	CcSEcCtD
Doxepin—Discomfort—Doxorubicin—pancreatic cancer	5.07e-05	0.000379	CcSEcCtD
Doxepin—Anorexia—Epirubicin—pancreatic cancer	5.07e-05	0.000379	CcSEcCtD
Doxepin—Dry mouth—Doxorubicin—pancreatic cancer	5.02e-05	0.000375	CcSEcCtD
Doxepin—Vomiting—Docetaxel—pancreatic cancer	5.01e-05	0.000375	CcSEcCtD
Doxepin—Rash—Docetaxel—pancreatic cancer	4.97e-05	0.000372	CcSEcCtD
Doxepin—Hypotension—Epirubicin—pancreatic cancer	4.97e-05	0.000372	CcSEcCtD
Doxepin—Dermatitis—Docetaxel—pancreatic cancer	4.97e-05	0.000371	CcSEcCtD
Doxepin—Confusional state—Doxorubicin—pancreatic cancer	4.96e-05	0.000371	CcSEcCtD
Doxepin—Headache—Docetaxel—pancreatic cancer	4.94e-05	0.000369	CcSEcCtD
Doxepin—Oedema—Doxorubicin—pancreatic cancer	4.92e-05	0.000368	CcSEcCtD
Doxepin—Infection—Doxorubicin—pancreatic cancer	4.89e-05	0.000365	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.85e-05	0.000362	CcSEcCtD
Doxepin—Shock—Doxorubicin—pancreatic cancer	4.84e-05	0.000362	CcSEcCtD
Doxepin—Nervous system disorder—Doxorubicin—pancreatic cancer	4.83e-05	0.000361	CcSEcCtD
Doxepin—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.82e-05	0.00036	CcSEcCtD
Doxepin—Insomnia—Epirubicin—pancreatic cancer	4.81e-05	0.00036	CcSEcCtD
Doxepin—Tachycardia—Doxorubicin—pancreatic cancer	4.8e-05	0.000359	CcSEcCtD
Doxepin—Skin disorder—Doxorubicin—pancreatic cancer	4.78e-05	0.000357	CcSEcCtD
Doxepin—Paraesthesia—Epirubicin—pancreatic cancer	4.78e-05	0.000357	CcSEcCtD
Doxepin—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.76e-05	0.000356	CcSEcCtD
Doxepin—Dyspnoea—Epirubicin—pancreatic cancer	4.74e-05	0.000354	CcSEcCtD
Doxepin—Somnolence—Epirubicin—pancreatic cancer	4.73e-05	0.000353	CcSEcCtD
Doxepin—Anorexia—Doxorubicin—pancreatic cancer	4.69e-05	0.000351	CcSEcCtD
Doxepin—Nausea—Docetaxel—pancreatic cancer	4.68e-05	0.00035	CcSEcCtD
Doxepin—Dyspepsia—Epirubicin—pancreatic cancer	4.68e-05	0.00035	CcSEcCtD
Doxepin—Decreased appetite—Epirubicin—pancreatic cancer	4.62e-05	0.000346	CcSEcCtD
Doxepin—Hypotension—Doxorubicin—pancreatic cancer	4.6e-05	0.000344	CcSEcCtD
Doxepin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.59e-05	0.000343	CcSEcCtD
Doxepin—Fatigue—Epirubicin—pancreatic cancer	4.59e-05	0.000343	CcSEcCtD
Doxepin—Constipation—Epirubicin—pancreatic cancer	4.55e-05	0.00034	CcSEcCtD
Doxepin—Pain—Epirubicin—pancreatic cancer	4.55e-05	0.00034	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.48e-05	0.000335	CcSEcCtD
Doxepin—Insomnia—Doxorubicin—pancreatic cancer	4.45e-05	0.000333	CcSEcCtD
Doxepin—Paraesthesia—Doxorubicin—pancreatic cancer	4.42e-05	0.00033	CcSEcCtD
Doxepin—Dyspnoea—Doxorubicin—pancreatic cancer	4.39e-05	0.000328	CcSEcCtD
Doxepin—Feeling abnormal—Epirubicin—pancreatic cancer	4.38e-05	0.000328	CcSEcCtD
Doxepin—Somnolence—Doxorubicin—pancreatic cancer	4.38e-05	0.000327	CcSEcCtD
Doxepin—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.35e-05	0.000325	CcSEcCtD
Doxepin—Dyspepsia—Doxorubicin—pancreatic cancer	4.33e-05	0.000324	CcSEcCtD
Doxepin—Decreased appetite—Doxorubicin—pancreatic cancer	4.28e-05	0.00032	CcSEcCtD
Doxepin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.25e-05	0.000318	CcSEcCtD
Doxepin—Fatigue—Doxorubicin—pancreatic cancer	4.24e-05	0.000317	CcSEcCtD
Doxepin—Urticaria—Epirubicin—pancreatic cancer	4.23e-05	0.000316	CcSEcCtD
Doxepin—Constipation—Doxorubicin—pancreatic cancer	4.21e-05	0.000315	CcSEcCtD
Doxepin—Pain—Doxorubicin—pancreatic cancer	4.21e-05	0.000315	CcSEcCtD
Doxepin—Body temperature increased—Epirubicin—pancreatic cancer	4.2e-05	0.000314	CcSEcCtD
Doxepin—Abdominal pain—Epirubicin—pancreatic cancer	4.2e-05	0.000314	CcSEcCtD
Doxepin—Feeling abnormal—Doxorubicin—pancreatic cancer	4.06e-05	0.000303	CcSEcCtD
Doxepin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.02e-05	0.000301	CcSEcCtD
Doxepin—Hypersensitivity—Epirubicin—pancreatic cancer	3.92e-05	0.000293	CcSEcCtD
Doxepin—Urticaria—Doxorubicin—pancreatic cancer	3.91e-05	0.000292	CcSEcCtD
Doxepin—Abdominal pain—Doxorubicin—pancreatic cancer	3.89e-05	0.000291	CcSEcCtD
Doxepin—Body temperature increased—Doxorubicin—pancreatic cancer	3.89e-05	0.000291	CcSEcCtD
Doxepin—Asthenia—Epirubicin—pancreatic cancer	3.82e-05	0.000285	CcSEcCtD
Doxepin—Pruritus—Epirubicin—pancreatic cancer	3.76e-05	0.000281	CcSEcCtD
Doxepin—Diarrhoea—Epirubicin—pancreatic cancer	3.64e-05	0.000272	CcSEcCtD
Doxepin—Hypersensitivity—Doxorubicin—pancreatic cancer	3.63e-05	0.000271	CcSEcCtD
Doxepin—Asthenia—Doxorubicin—pancreatic cancer	3.53e-05	0.000264	CcSEcCtD
Doxepin—Dizziness—Epirubicin—pancreatic cancer	3.52e-05	0.000263	CcSEcCtD
Doxepin—Pruritus—Doxorubicin—pancreatic cancer	3.48e-05	0.00026	CcSEcCtD
Doxepin—Vomiting—Epirubicin—pancreatic cancer	3.38e-05	0.000253	CcSEcCtD
Doxepin—Diarrhoea—Doxorubicin—pancreatic cancer	3.37e-05	0.000252	CcSEcCtD
Doxepin—Rash—Epirubicin—pancreatic cancer	3.35e-05	0.000251	CcSEcCtD
Doxepin—Dermatitis—Epirubicin—pancreatic cancer	3.35e-05	0.00025	CcSEcCtD
Doxepin—Headache—Epirubicin—pancreatic cancer	3.33e-05	0.000249	CcSEcCtD
Doxepin—Dizziness—Doxorubicin—pancreatic cancer	3.25e-05	0.000243	CcSEcCtD
Doxepin—Nausea—Epirubicin—pancreatic cancer	3.16e-05	0.000236	CcSEcCtD
Doxepin—Vomiting—Doxorubicin—pancreatic cancer	3.13e-05	0.000234	CcSEcCtD
Doxepin—Rash—Doxorubicin—pancreatic cancer	3.1e-05	0.000232	CcSEcCtD
Doxepin—Dermatitis—Doxorubicin—pancreatic cancer	3.1e-05	0.000232	CcSEcCtD
Doxepin—Headache—Doxorubicin—pancreatic cancer	3.08e-05	0.00023	CcSEcCtD
Doxepin—Nausea—Doxorubicin—pancreatic cancer	2.92e-05	0.000219	CcSEcCtD
Doxepin—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	2.29e-06	2.2e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.29e-06	2.19e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	2.29e-06	2.19e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.29e-06	2.19e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	2.29e-06	2.19e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—pancreatic cancer	2.29e-06	2.19e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—HRAS—pancreatic cancer	2.28e-06	2.18e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	2.28e-06	2.18e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	2.28e-06	2.18e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	2.27e-06	2.18e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	2.27e-06	2.18e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PTEN—pancreatic cancer	2.27e-06	2.17e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	2.27e-06	2.17e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	2.26e-06	2.17e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	2.26e-06	2.17e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	2.25e-06	2.16e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	2.25e-06	2.15e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—pancreatic cancer	2.25e-06	2.15e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	2.25e-06	2.15e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	2.25e-06	2.15e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—pancreatic cancer	2.25e-06	2.15e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	2.25e-06	2.15e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—pancreatic cancer	2.24e-06	2.15e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	2.24e-06	2.14e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	2.24e-06	2.14e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	2.24e-06	2.14e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	2.23e-06	2.14e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.23e-06	2.14e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PTEN—pancreatic cancer	2.23e-06	2.14e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	2.23e-06	2.13e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	2.23e-06	2.13e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	2.23e-06	2.13e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	2.23e-06	2.13e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	2.22e-06	2.13e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	2.22e-06	2.13e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	2.22e-06	2.12e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	2.22e-06	2.12e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	2.21e-06	2.11e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	2.2e-06	2.11e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	2.2e-06	2.11e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	2.2e-06	2.1e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	2.2e-06	2.1e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	2.19e-06	2.1e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	2.19e-06	2.09e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	2.18e-06	2.09e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	2.18e-06	2.09e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—pancreatic cancer	2.18e-06	2.08e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	2.18e-06	2.08e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	2.17e-06	2.08e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	2.17e-06	2.07e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	2.16e-06	2.07e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—pancreatic cancer	2.16e-06	2.06e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	2.15e-06	2.06e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—pancreatic cancer	2.15e-06	2.06e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	2.15e-06	2.05e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	2.14e-06	2.05e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—pancreatic cancer	2.14e-06	2.05e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	2.14e-06	2.04e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	2.13e-06	2.04e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.13e-06	2.04e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.13e-06	2.04e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	2.11e-06	2.02e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	2.11e-06	2.02e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SRC—pancreatic cancer	2.11e-06	2.02e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.11e-06	2.01e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	2.1e-06	2.01e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	2.1e-06	2.01e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	2.09e-06	2e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	2.09e-06	2e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.09e-06	2e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	2.08e-06	1.99e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	2.08e-06	1.99e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	2.08e-06	1.99e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SRC—pancreatic cancer	2.07e-06	1.98e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SRC—pancreatic cancer	2.07e-06	1.98e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SRC—pancreatic cancer	2.06e-06	1.97e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	2.06e-06	1.97e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	2.06e-06	1.97e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SRC—pancreatic cancer	2.06e-06	1.97e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	2.05e-06	1.96e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	2.05e-06	1.96e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	2.05e-06	1.96e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	2.04e-06	1.96e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SRC—pancreatic cancer	2.04e-06	1.95e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	2.04e-06	1.95e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	2.03e-06	1.95e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—pancreatic cancer	2.03e-06	1.95e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	2.03e-06	1.94e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.03e-06	1.94e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NRAS—pancreatic cancer	2.03e-06	1.94e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	2.03e-06	1.94e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	2.02e-06	1.93e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	2.02e-06	1.93e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—pancreatic cancer	2.02e-06	1.93e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	2.01e-06	1.92e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	2e-06	1.92e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	2e-06	1.92e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	2e-06	1.91e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—pancreatic cancer	2e-06	1.91e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	2e-06	1.91e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.99e-06	1.91e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NRAS—pancreatic cancer	1.99e-06	1.91e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	1.99e-06	1.9e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	1.99e-06	1.9e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	1.98e-06	1.9e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	1.98e-06	1.9e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	1.98e-06	1.9e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	1.98e-06	1.9e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	1.98e-06	1.89e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	1.98e-06	1.89e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	1.98e-06	1.89e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.98e-06	1.89e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	1.96e-06	1.88e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	1.96e-06	1.87e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	1.96e-06	1.87e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.96e-06	1.87e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	1.95e-06	1.87e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.95e-06	1.86e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	1.94e-06	1.86e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.93e-06	1.85e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	1.92e-06	1.84e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	1.9e-06	1.82e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	1.89e-06	1.81e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	1.89e-06	1.81e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—pancreatic cancer	1.89e-06	1.81e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	1.89e-06	1.81e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	1.88e-06	1.8e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PIK3CA—pancreatic cancer	1.87e-06	1.79e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—pancreatic cancer	1.86e-06	1.78e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—pancreatic cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—pancreatic cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—pancreatic cancer	1.85e-06	1.77e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	1.84e-06	1.76e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—pancreatic cancer	1.84e-06	1.76e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	1.84e-06	1.76e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	1.84e-06	1.76e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	1.84e-06	1.76e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.83e-06	1.76e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	1.83e-06	1.75e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.83e-06	1.75e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—pancreatic cancer	1.82e-06	1.75e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	1.82e-06	1.74e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	1.82e-06	1.74e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	1.82e-06	1.74e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	1.82e-06	1.74e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.82e-06	1.74e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.82e-06	1.74e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	1.82e-06	1.74e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	1.82e-06	1.74e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	1.82e-06	1.74e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	1.82e-06	1.74e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—pancreatic cancer	1.81e-06	1.74e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	1.81e-06	1.73e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.8e-06	1.72e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	1.8e-06	1.72e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	1.78e-06	1.71e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.78e-06	1.71e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	1.78e-06	1.7e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	1.77e-06	1.69e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—pancreatic cancer	1.77e-06	1.69e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—pancreatic cancer	1.76e-06	1.68e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	1.75e-06	1.67e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—KRAS—pancreatic cancer	1.75e-06	1.67e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	1.74e-06	1.66e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—pancreatic cancer	1.73e-06	1.66e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—pancreatic cancer	1.73e-06	1.65e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.72e-06	1.65e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	1.72e-06	1.64e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	1.72e-06	1.64e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—KRAS—pancreatic cancer	1.71e-06	1.64e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	1.71e-06	1.64e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	1.71e-06	1.64e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	1.71e-06	1.63e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	1.7e-06	1.63e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	1.69e-06	1.62e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	1.69e-06	1.62e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	1.69e-06	1.61e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	1.69e-06	1.61e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTEN—pancreatic cancer	1.68e-06	1.61e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	1.68e-06	1.61e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	1.68e-06	1.61e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	1.68e-06	1.61e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	1.65e-06	1.58e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	1.63e-06	1.56e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	1.61e-06	1.54e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	1.6e-06	1.53e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.59e-06	1.52e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	1.58e-06	1.51e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	1.57e-06	1.51e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.57e-06	1.5e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	1.57e-06	1.5e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.57e-06	1.5e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	1.56e-06	1.5e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	1.56e-06	1.49e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.55e-06	1.49e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—pancreatic cancer	1.55e-06	1.48e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.55e-06	1.48e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	1.55e-06	1.48e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.54e-06	1.48e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.54e-06	1.47e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—pancreatic cancer	1.53e-06	1.46e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—pancreatic cancer	1.53e-06	1.46e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—pancreatic cancer	1.52e-06	1.46e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—pancreatic cancer	1.52e-06	1.45e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—pancreatic cancer	1.51e-06	1.45e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.51e-06	1.45e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—pancreatic cancer	1.5e-06	1.43e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	1.49e-06	1.43e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	1.49e-06	1.43e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	1.48e-06	1.42e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HRAS—pancreatic cancer	1.48e-06	1.42e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	1.46e-06	1.4e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HRAS—pancreatic cancer	1.46e-06	1.39e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	1.45e-06	1.39e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	1.45e-06	1.38e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	1.44e-06	1.38e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	1.44e-06	1.37e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	1.43e-06	1.37e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	1.43e-06	1.37e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	1.42e-06	1.36e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—pancreatic cancer	1.4e-06	1.34e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	1.39e-06	1.33e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.38e-06	1.32e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.34e-06	1.29e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—pancreatic cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—pancreatic cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	1.28e-06	1.23e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.27e-06	1.21e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	1.26e-06	1.21e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.22e-06	1.16e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.2e-06	1.15e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.12e-06	1.07e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.04e-06	9.92e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—pancreatic cancer	9.93e-07	9.51e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—pancreatic cancer	9.7e-07	9.28e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	9.48e-07	9.07e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—pancreatic cancer	9.14e-07	8.74e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—pancreatic cancer	9.06e-07	8.67e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—pancreatic cancer	7.74e-07	7.41e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	7.31e-07	7e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—pancreatic cancer	5.97e-07	5.72e-06	CbGpPWpGaD
